{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:33:58Z","timestamp":1761129238226},"reference-count":59,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1097\/cpm.0000000000000097","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T18:46:58Z","timestamp":1435085218000},"page":"185-191","source":"Crossref","is-referenced-by-count":2,"title":["Biomarker Kinetics in VAP"],"prefix":"10.1097","volume":"22","author":[{"given":"Pedro","family":"P\u00f3voa","sequence":"first","affiliation":[]},{"given":"Ignacio","family":"Martin-Loeches","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Artigas","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"803","DOI":"10.7326\/0003-4819-147-11-200712040-00013","article-title":"Ventilator-associated pneumoniathe wrong quality measure for benchmarking.","volume":"147","author":"Klompas","year":"2007","journal-title":"Ann Internal Med"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S1473-3099(13)70081-1","article-title":". Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies.","volume":"13","author":"Melsen","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R3-5-20210129","first-page":"1S59","article-title":"Ventilator-associated tracheobronchitis and pneumonia: thinking outside the box.","volume":"51suppl","author":"Craven","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1473-3099(13)70001-X","article-title":"Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/cc10332","article-title":". The late phase of sepsis is characterized by an increased microbiological burden and death rate.","volume":"15","author":"Otto","year":"2011","journal-title":"Crit Care"},{"key":"R6-5-20210129","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1164\/rccm.200609-1322OC","article-title":". Herpes simplex virus lung infection in patients undergoing prolonged mechanical ventilation.","volume":"175","author":"Luyt","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"R7-5-20210129","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(93)90060-3","article-title":". Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay.","volume":"94","author":"Fagon","year":"1993","journal-title":"Am J Med"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1164\/rccm.201105-0867OC","article-title":". Attributable mortality of ventilator-associated pneumonia: a reappraisal using causal analysis.","volume":"184","author":"Bekaert","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Infectious Diseases Society of A. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.","volume":"171","author":"American Thoracic","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ajem.2012.08.041","article-title":". High discordance of chest x-ray and computed tomography for detection of pulmonary opacities in ED patients: implications for diagnosing pneumonia.","volume":"31","author":"Self","year":"2013","journal-title":"Am J Emerg Med"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/thx.2008.110239","article-title":". Evaluation of the effect of diagnostic methodology on the reported incidence of ventilator-associated pneumonia.","volume":"64","author":"Morris","year":"2009","journal-title":"Thorax"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1086\/524332","article-title":"Development of an algorithm for surveillance of ventilator-associated pneumonia with electronic data and comparison of algorithm results with clinician diagnoses.","volume":"29","author":"Klompas","year":"2008","journal-title":"Infect Control Hosp Epidemiol"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00.16596900","article-title":". Diagnostic accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia.","volume":"16","author":"Bregeon","year":"2000","journal-title":"Eur Respir J"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/thx.54.10.867","article-title":". Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies.","volume":"54","author":"Fabregas","year":"1999","journal-title":"Thorax"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1164\/rccm.200212-1449OC","article-title":". Diagnosing pneumonia during mechanical ventilation: the clinical pulmonary infection score revisited.","volume":"168","author":"Fartoukh","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1007\/s00134-008-1112-x","article-title":". Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.","volume":"34","author":"Luyt","year":"2008","journal-title":"Intensive Care Med"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00134-010-1833-5","article-title":". Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.","volume":"36","author":"Jung","year":"2010","journal-title":"Intensive Care Med"},{"key":"R20-5-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/01.CCM.0000055380.86458.1E","article-title":". Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.","volume":"31","author":"Luna","year":"2003","journal-title":"Crit Care Med"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.200406-746OC","article-title":". Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia.","volume":"171","author":"Luyt","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/QCO.0b013e3282f47c32","article-title":"Serum markers in community-acquired pneumonia and ventilator-associated pneumonia.","volume":"21","author":"Povoa","year":"2008","journal-title":"Curr Opin Infect Dis"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1471-2334-8-163","article-title":". Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients.","volume":"8","author":"Charles","year":"2008","journal-title":"BMC Infect Dis"},{"key":"R24-5-20210129","first-page":"211","article-title":"ProCon debate: is procalcitonin useful for guiding antibiotic decision making in critically ill patients Crit Care.","volume":"12","author":"Shehabi","year":"2008","journal-title":""},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":". Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis.","volume":"7","author":"Tang","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"R27-5-20210129","first-page":"300","article-title":"An expert report of the European Society of Intensive Care Medicine.","volume":"20","year":"1994","journal-title":"Intensive Care Med"},{"key":"R28-5-20210129","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00003246-200104000-00039","article-title":". New strategies for clinical trials in patients with sepsis and septic shock.","volume":"29","author":"Cohen","year":"2001","journal-title":"Crit Care Med"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1469-0691.2004.01044.x","article-title":". C-reactive protein as a marker of infection in critically ill patients.","volume":"11","author":"Povoa","year":"2005","journal-title":"Clin Microbiol Infect"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00134-009-1681-3","article-title":". Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.","volume":"36","author":"Mongardon","year":"2010","journal-title":"Intensive Care Med"},{"key":"R32-5-20210129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00086707","article-title":". Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia.","volume":"31","author":"Ramirez","year":"2008","journal-title":"Eur Respir J"},{"key":"R33-5-20210129","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1183\/09031936.05.00071704","article-title":". C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study.","volume":"25","author":"Povoa","year":"2005","journal-title":"Eur Respir J"},{"key":"R34-5-20210129","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","article-title":"C-reactive protein: a valuable marker of sepsis.","volume":"28","author":"Povoa","year":"2002","journal-title":"Intensive Care Med"},{"key":"R35-5-20210129","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1086\/430382","article-title":". Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection.","volume":"40","author":"Povoa","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R36-5-20210129","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc4892","article-title":". Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study.","volume":"10","author":"Povoa","year":"2006","journal-title":"Crit Care"},{"key":"R37-5-20210129","doi-asserted-by":"crossref","first-page":"R169","DOI":"10.1186\/cc10313","article-title":". C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study.","volume":"15","author":"Povoa","year":"2011","journal-title":"Crit Care"},{"key":"R38-5-20210129","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/CCM.0b013e31820a942c","article-title":". Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.","volume":"39","author":"El-Solh","year":"2011","journal-title":"Crit Care Med"},{"key":"R39-5-20210129","first-page":"251","article-title":"Procalcitonin - a new marker of host inflammatory response. Longitudinal studies in patients with sepsis and peritonitis.","volume":"11suppl","author":"Gramm","year":"1995","journal-title":"Chir Gastroenterol"},{"key":"R40-5-20210129","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1097\/00003246-200009000-00008","article-title":". Usefulness of procalcitonin for diagnosis of infection in cardiac surgical patients.","volume":"28","author":"Aouifi","year":"2000","journal-title":"Crit Care Med"},{"key":"R42-5-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1086\/341023","article-title":". Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever.","volume":"35","author":"Chirouze","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R43-5-20210129","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1186\/cc4866","article-title":". Procalcitonin, lipopolysaccharide-binding protein, interleukin-6 and C-reactive protein in community-acquired infections and sepsis: a prospective study.","volume":"10","author":"Gaini","year":"2006","journal-title":"Crit Care"},{"key":"R44-5-20210129","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1007\/s00134-005-2818-7","article-title":". Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia.","volume":"31","author":"Determann","year":"2005","journal-title":"Intensive Care Med"},{"key":"R45-5-20210129","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00134-014-3260-5","article-title":". The volatile metabolic fingerprint of ventilator-associated pneumonia.","volume":"40","author":"Bos","year":"2014","journal-title":"Intensive Care Med"},{"key":"R46-5-20210129","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.279.18.1452","article-title":". Time to clinical stability in patients hospitalized with community-acquired pneumonia: implications for practice guidelines.","volume":"279","author":"Halm","year":"1998","journal-title":"JAMA"},{"key":"R47-5-20210129","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1164\/ajrccm.163.6.2007020","article-title":". Resolution of infectious parameters after antimicrobial therapy in patients with ventilator-associated pneumonia.","volume":"163","author":"Dennesen","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R48-5-20210129","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1097\/01.CCM.0000165811.61232.D6","article-title":". Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with and without acute respiratory distress syndrome.","volume":"33","author":"Vidaur","year":"2005","journal-title":"Crit Care Med"},{"key":"R49-5-20210129","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1164\/ajrccm\/147.1.38","article-title":". Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia.","volume":"147","author":"Montravers","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"R50-5-20210129","first-page":"1082","article-title":"Hirschmann JV, et al..","volume":"159","author":"Wipf","year":"1999","journal-title":"Diagnosing pneumonia by physical examination: relevant or relic Arch Intern Med"},{"key":"R51-5-20210129","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1186\/cc5036","article-title":". Decreases in procalcitonin and C-reactive protein are strong predictors of survival in ventilator-associated pneumonia.","volume":"10","author":"Seligman","year":"2006","journal-title":"Crit Care"},{"key":"R52-5-20210129","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.CCM.0000297886.32564.CF","article-title":". C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia.","volume":"36","author":"Lisboa","year":"2008","journal-title":"Crit Care Med"},{"key":"R53-5-20210129","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jinf.2010.06.005","article-title":". C-reactive protein: a tool in the follow-up of nosocomial pneumonia.","volume":"61","author":"Moreno","year":"2010","journal-title":"J Infect"},{"key":"R54-5-20210129","doi-asserted-by":"crossref","first-page":"R92","DOI":"10.1186\/cc6105","article-title":". Usefulness of C-reactive protein in monitoring severe community-acquired pneumonia clinical course.","volume":"11","author":"Coelho","year":"2007","journal-title":"Crit Care"},{"key":"R55-5-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1378\/chest.122.1.262","article-title":". Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.","volume":"122","author":"Iregui","year":"2002","journal-title":"Chest"},{"key":"R56-5-20210129","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s15010-007-7077-9","article-title":"The time course of blood C-reactive protein concentrations in relation to the response to initial antimicrobial therapy in patients with sepsis.","volume":"36","author":"Schmit","year":"2008","journal-title":"Infection"},{"key":"R57-5-20210129","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1183\/09031936.00003608","article-title":". Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.","volume":"32","author":"Bruns","year":"2008","journal-title":"Eur Respir J"},{"key":"R58-5-20210129","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/eri.10.25","article-title":". Procalcitonin for guidance of antibiotic therapy.","volume":"8","author":"Schuetz","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"R59-5-20210129","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/cc8155","article-title":"Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia.","volume":"14","author":"Christ-Crain","year":"2010","journal-title":"Crit Care"},{"key":"R60-5-20210129","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1183\/09031936.00053209","article-title":". Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised study.","volume":"34","author":"Stolz","year":"2009","journal-title":"Eur Respir J"},{"key":"R61-5-20210129","first-page":"CD007498","article-title":". Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.","volume":"9","author":"Schuetz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"R62-5-20210129","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2110-5820-2-32","article-title":"Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review.","volume":"2","author":"Povoa","year":"2012","journal-title":"Ann Intensive Care"},{"key":"R63-5-20210129","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1001\/jama.290.19.2588","article-title":". Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.","volume":"290","author":"Chastre","year":"2003","journal-title":"JAMA"},{"key":"R64-5-20210129","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1378\/chest.125.5.1791","article-title":". A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia.","volume":"125","author":"Micek","year":"2004","journal-title":"Chest"}],"container-title":["Clinical Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CPM.0000000000000097","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:31:24Z","timestamp":1620952284000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045413-201507000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/cpm.0000000000000097","relation":{},"ISSN":["1068-0640"],"issn-type":[{"value":"1068-0640","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]}}}